| Literature DB >> 23756164 |
Arianne Pérez-García1, Gemma Osca, Anna Bosch-Vizcaya, Nichollas Kelleher, Nazly Y Santos, Rocío Rodríguez, Yolanda González, Josep M Roncero, Rosa Coll, Maite Serrando, Natàlia Lloveras, Esperanza Tuset, David Gallardo.
Abstract
Cytotoxic T lymphocyte antigen 4 (CTLA-4) plays a key inhibitory role during T lymphocyte activation. The CTLA4 gene is translated into two proteic isoforms: a full-length protein (flCTLA-4) and a soluble counterpart. We explored the expression of both isoforms on healthy subjects. Whereas in non-stimulated cells the flCTLA-4 isoform is predominant, after stimulation the expression of the soluble form rapidly increases, reaching its maximum 24h after and falling again to the basal levels 72 h after stimulation. In contrast, the flCTLA-4 mRNA levels increase is slower, reaching the maximum level 72 h after stimulation. The presence of the T allele in the promoter positions -1722 and -318 is associated with an increased transcriptional activity and this effect seems to be synergic. We conclude that the kinetics of CTLA-4 isoform expression are sequential, and that the promoter polymorphisms -1722(C/T) and -318(C/T) are involved in the control of the CTLA4 transcription.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23756164 DOI: 10.1016/j.humimm.2013.05.012
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850